DOTSON JERROLD DUANE 4
4 · VistaGen Therapeutics, Inc. · Filed Jan 12, 2022
Insider Transaction Report
Form 4
DOTSON JERROLD DUANE
ACTING CFO
Transactions
- Exercise/Conversion
Common Stock
2022-01-11$1.00/sh+18,750$18,750→ 94,571 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-01-11−18,750→ 15,625 totalExercise: $1.00Exp: 2029-05-23→ Common Stock (34,375 underlying)
Footnotes (1)
- [F1]25% of the shares subject to this stock option vested May 23, 2019, with the the remaining shares vesting in 1/36th installments on each monthly anniversary thereafter.